NCT00002634View on ClinicalTrials.gov

Chemotherapy, Radiation Therapy, Immunotherapy, and Bone Marrow Transplantation in Treating Patients With Neuroblastoma

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

February 28, 1995

Primary Completion Date

September 30, 2004

Study Completion Date

September 30, 2004

Conditions
Neuroblastoma
Interventions
BIOLOGICAL

filgrastim

BIOLOGICAL

monoclonal antibody 3F8

DRUG

cisplatin

DRUG

cyclophosphamide

DRUG

doxorubicin hydrochloride

DRUG

etoposide

DRUG

mesna

DRUG

perfosfamide

DRUG

vincristine sulfate

PROCEDURE

autologous bone marrow transplantation

PROCEDURE

in vitro-treated bone marrow transplantation

RADIATION

low-LET cobalt-60 gamma ray therapy

RADIATION

low-LET photon therapy

RADIATION

radioisotope therapy

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER